Role of surgery for stage IIIA-N2 non-small cell lung cancer

被引:2
|
作者
Yang, Fan [1 ]
Wang, Jun [1 ]
机构
[1] Peking Univ People Hosp, Dept Thorac Surg, Beijing 100044, Peoples R China
关键词
Non-small cell lung cancer; stage IIIA-N2; surgery; CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM SURVIVAL; INDUCTION CHEMOTHERAPY; SURGICAL RESECTION; NEOADJUVANT CHEMOTHERAPY; 2ND EDITION; PHASE-III; THERAPY; PNEUMONECTOMY;
D O I
10.1111/j.1759-7714.2011.00048.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Perhaps no topic other than stage IIIA-N2 non-small-cell lung cancer management is as controversial among surgeons, radiologists and medical oncologists. Much of the debate relates to the choice between surgical resection and radiation as the local controlmodality. Although limited, available evidence from randomized controlled trails raised concerns about the role of surgical resection. However, there is no perfect study, and the results should not be over-interpreted. This mini review will scrutinize these trials, focusing on the study design, results and, most importantly, limitations, and will explore the possible role of surgery for stage IIIA-N2 non-small-cell lung cancer.
引用
收藏
页码:90 / 94
页数:5
相关论文
共 50 条
  • [1] Surgery for stage IIIA-N2 non-small cell lung cancer: the jury is still out!
    Berzenji, Lawek
    Beckers, Paul
    Van Schil, Paul E.
    JOURNAL OF THORACIC DISEASE, 2019, 11 : S1153 - S1156
  • [2] Neoadjuvant chemotherapy for stage IIIA-N2 non-small cell lung cancer
    De Marinis, Filippo
    Gebbia, V.
    De Petris, L.
    ANNALS OF ONCOLOGY, 2005, 16 : 116 - 122
  • [3] A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery
    Mao, Qixing
    Xia, Wenjie
    Dong, Gaochao
    Chen, Shuqi
    Wang, Anpeng
    Jin, Guangfu
    Jiang, Feng
    Xu, Lin
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 155 (04): : 1784 - +
  • [4] Surgery as a Component of Multimodality Care for Known Stage IIIA-N2 Non-small Cell Lung Cancer
    Bograd, Adam J.
    Vallieres, Eric
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 346 - 353
  • [5] A Nomogram to Predict the Survival of Stage IIIA-N2 Non-Small Cell Lung Cancer After Surgery
    Mao, Q.
    Xu, L.
    Jiang, F.
    Yin, R.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2374 - S2375
  • [6] Is surgery indicated for stage IIIA-N2 non-small-cell lung cancer?
    Gounant, V.
    Lavole, A.
    Epaud, C.
    Rosencher, L.
    Milleron, B.
    REVUE DE PNEUMOLOGIE CLINIQUE, 2007, 63 (03) : 135 - 137
  • [7] Induction erlotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong Wen-Zhao
    Yang Xue-Ning
    Guo Ai-Lin
    Chen Hua-Jun
    Su Jian
    Liao Ri-Qiang
    Zhou Qing
    Nie Qiang
    Xu Chong-Rui
    Yang Jin-Ji
    Wu Yi-Long
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S590 - S591
  • [8] Induction eriotinib therapy in stage IIIA-N2 non-small cell lung cancer
    Zhong, W.
    Yang, X.
    Liao, R.
    Nie, Q.
    Zhang, X.
    Su, J.
    Zhou, Q.
    Xu, C.
    Yang, J.
    Wu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [9] The role of surgery in stage IIIA non-small cell lung cancer
    Eberhardt, WEE
    Hepp, R
    Stamatis, G
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2005, 19 (02) : 303 - +
  • [10] Optimal Treatment of Stage IIIA-N2 Non-Small Cell Lung Cancer: A Neverending Story?
    Van Schil, Paul E.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (09) : 1338 - 1340